CAR T-cell therapy (Innovative Cellular Therapeutics/Qilu Hospital of Shandong University)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug NameCAR T-cell therapy (Innovative Cellular Therapeutics/Qilu Hospital of Shandong University)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapyBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionImmunostimulantsT lymphocytes stimulants
TargetsUpdating
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesQilu Hospital Of Shandong University
China Registration ClassN/A

Develop Information

Active CompaniesQilu Hospital Of Shandong UniversityInnovative Cellular Therapeutics Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A